david ghesquiere  nanostring technologies inc  zoominfocom   microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft david w ghesquiere  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in david w ghesquiere senior vice president corporate and business development at nanostring technologies inc view full profile are you david w ghesquiere claim your profile   sign up for equilar atlas and view david w ghesquieres full profile with equilar atlas you can identify corporate executives in david w ghesquieres network and community follow changes in david w ghesquieres employment and moneyinmotion connect with david w ghesquiere through your network of contacts david w ghesquieres executive work history current senior vice president corporate and business development nanostring technologies inc past to view david w ghesquieres complete executive work history sign up now age      david w ghesquieres biography david w ghesquiere has served as senior vice president corporate  business development since november  prior to joining our company mr ghesquiere was the founder and managing director of adrenaline venture  advisory llc an international advisory firm from august  to november  prior to founding adrenaline venture  advisory mr ghesquiere served as senior vice president corporate  business development at dendreon corporation a biotechnology company from  to  from  to  mr ghesquiere held a variety of executive positions at osi pharmaceuticals acquired by astellas pharma in  including senior vi  read more david w ghesquiere has served as senior vice president corporate  business development since november  prior to joining our company mr ghesquiere was the founder and managing director of adrenaline venture  advisory llc an international advisory firm from august  to november  prior to founding adrenaline venture  advisory mr ghesquiere served as senior vice president corporate  business development at dendreon corporation a biotechnology company from  to  from  to  mr ghesquiere held a variety of executive positions at osi pharmaceuticals acquired by astellas pharma in  including senior vicepresident of corporate  business development and managing director of osi investment holdings gmbh and osi investment management gmbh osis wholly owned switzerlandbased subsidiaries where he played a key role in establishing osis venture capital arm earlier in his career mr ghesquiere served as director of global business development for aventis pharmaceuticals which merged with sanofi in  and worked in product marketing at johnson  johnson mr ghesquiere received an mba from the university of western ontarios ivey school of business and a ba in economics from the university of western ontario source nanostring technologies inc on    sign up for equilar atlas and view david w ghesquieres full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like david w ghesquiere more specifically youll be able to identify corporate executives in david w ghesquieres network and community follow changes in david w ghesquieres employment and moneyinmotion connect with david w ghesquiere through your network of conections view full profile   search for over  executive profiles bio example david w ghesquiere david w ghesquieres connections  sign up now to view david w ghesquieres  connections » bradford j crutchfield former executive vice president and president life science group biorad laboratories inc r bradley gray dir president and chief executive officer nanostring technologies inc wayne d burns former senior vice president operations and administration nanostring technologies inc joseph m beechem senior vice president research and development nanostring technologies inc charles p waite board member nanostring technologies inc bruce j seeley principal financial officer executive vice president chief commercial and administrative officer and secretary cti biopharma corp william d young chairman nanostring technologies inc james a johnson chief financial officer nanostring technologies inc gregory norden board member nanostring technologies inc kirk malloy lead independent director organovo holdings inc popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith carl g annessa evp and coo hornbeck offshore services inc elon r musk ceo and chairman tesla michael c montgomery board member nmi holdings inc × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login ï¿½  equilar all rights reserved privacy policy  marshall street redwood city ca   phone 6   fax 6  nanostring technologies names david w ghesquiere senior vice president corporate  business development  firstword medtech login  subscribe friday july   get unlimited medtech plus subscriptions for one low fixed rate with a firstword medtech country licenseclick here for more details home my newsall my news my companywatch my conditionwatch my marketsegmentwatch my medicalmeetingwatch my productwatch my regulatorywatch all newsexplore latest news all company news all condition news all medical meeting news all product news all market segment news all regulatory market and agency news all therapeutic category news most popularmost popular in the last  hours most popular in the last  days most popular in the last  days storywatchduodenoscope reprocessing in focus emerging markets latest earnings reports pharma alliances product approvals and certifications us vaginalmesh product lawsuits where health meets tech servicesmobile search twitter rss podcasts radio nanostring technologies names david w ghesquiere senior vice president corporate  business development ref business wire november th  tags corporate affairs ivds nanostring tweet email print november    pm eastern standard time seattlebusiness wirenanostring technologies inc nasdaq nstg a provider of life science tools for translational research and molecular diagnostic products today announced the appointment of david w ghesquiere as senior vice president corporate  business development effective immediately in this role mr ghesquiere will work with nanostring’s chief executive officer brad gray to shape the strategy of the company while leading nanostring’s corporate and business development efforts his responsibilities will include pursuing growthoriented collaborations transactions and strategic initiatives to leverage and build the company’s technology base diagnostic test pipeline and other value drivers mr ghesquiere joins nanostring with over  years of experience in the biopharmaceutical industry in both north america and europe mr ghesquiere was most recently senior vice president corporate  business development at dendreon corporation where his primary responsibility was leading the strategic process to identify and pursue next generation technologies and therapeutics previously he was an executive at osi pharmaceuticals acquired by astellas where from  to  he held positions of increasing responsibility including senior vicepresident of corporate  business development and served as a board member and managing director  secretary of osi investment holdings gmbh  osi investment management gmbh earlier in his career mr ghesquiere was director of global business development for aventis pharmaceuticals acquired by sanofi and worked in product marketing at johnson  johnson “david has a deep background in the drug development industry and oncology two areas of importance to our strategy” said brad gray president and ceo of nanostring technologies “the addition of david to our executive team will accelerate our efforts to strengthen our menu of molecular diagnostics and extend our reach and impact in the area of oncology drug development” “i believe that molecular diagnostics and nanostring’s ncounter technology in particular will play an important role in improving the lives of patients with cancer and other diseases as the vision of personalized medicine becomes a reality” said mr ghesquiere “i am delighted to join the company to help map out the future for this disruptive technology platform with the potential to revolutionize the practice of oncology” the ncounter analysis system for research applications and the ncounter dx analysis system for highcomplexity cliacertified laboratories are highly automated and easytouse platforms that utilize nanostring’s novel digital barcoding chemistry to deliver high precision multiplexed assays the ncounter dx analysis system supports the prosigna breast cancer prognostic gene signature assay an in vitro diagnostic assay that uses the gene expression profile of cells found in breast cancer tissue to assess a patient’s risk of distant recurrence of disease the prosigna assay is the first in what the company expects to be a portfolio of genomic assays that will benefit cancer patients and oncologists in making treatment decisions about nanostring technologies inc nanostring technologies provides life science tools for translational research and molecular diagnostic products the companys ncounter® analysis system which has been employed in basic and translational research since it was first introduced in  and cited in more than  peerreviewed publications has also now been applied to diagnostic use as the ncounter dx analysis system the companys technology offers a costeffective way to easily profile the expression of hundreds of genes mirnas or copy number variations simultaneously with high sensitivity and precision the companys technology enables a wide variety of basic research and translational medicine applications including biomarker discovery and validation the ncounterbased prosigna™ breast cancer prognostic gene signature assay is the first in vitro diagnostic assay to be marketed through the companys diagnostics business the ncounter dx analysis system is fda k cleared for use with the prosigna breast cancer prognostic gene signature assay to date it has not been cleared by the fda for other indications or for use with other assays the prosigna assay has been cemarked and is available for use by healthcare professionals in the european union and other countries that recognize the ce mark and in which prosigna is registered for more information please visit wwwnanostringcom forward looking statements this press release contains forwardlooking statements within the meaning of the private securities litigation reform act of  including statements regarding the development of additional diagnostic tests and establishment of collaborations or other transactions related to oncology drug development forwardlooking statements are subject to risks and uncertainties that could cause actual results to differ materially and reported results should not be considered as an indication of future performance these risks and uncertainties include but are not limited to risks associated with keeping pace with rapidly changing technology and customer requirements risks regarding our ability to successfully introduce new products risks regarding acceptance of our products by oncologists and companies involved in drug development risks that new market opportunities may not develop as quickly as expected risks associated with competition in marketing and selling products risks of increased regulatory requirements as well as the other risks set forth in the companys filings with the securities and exchange commission these forwardlooking statements speak only as of the date hereof nanostring technologies disclaims any obligation to update these forwardlooking statements the nanostring technologies logo nanostring nanostring technologies ncounter prosigna and ncounter elements are trademarks or registered trademarks of nanostring technologies inc in various jurisdictions contacts for nanostring technologies maurissa messier of bioscribe inc 6 maurissabioscribecom did you like this article share this article twitter facebook google digg email print   related newsnanostring technologies names bruce seeley senior vice president  general manager diagnosticsnanostring technologies names joseph m beechem senior vice president of rdadaptive biotechnologies welcomes charles sang as senior vice president of diagnosticsnanostring appoints j chad brown as senior vice president of sales and marketinghealthtell inc hires gary riordan as new vice president of regulatory and quality reference articlesnanostring technologies names david w ghesquiere senior vice president corporate  business development  business wire recent reports effective sales and marketing strategies for drugs with companion diagnostics ref firstword dossierpatientcentricity solving the latest pharma puzzle ref firstword dossierbiosimilar defensive plays – assessing the options ref firstword dossier about firstword medtech  refer a colleague  upgrade your firstword medtech  contact firstword medtech  firstword reportsadvertise with firstword medtech  industry partner showcaseall contents copyright   doctors guide publishing limited all rights reservedterms of use  privacy policy nanostring technologies names david w ghesquiere senior vice president corporate  business development  business wire nanostring technologies names david w ghesquiere senior vice president corporate  business development november    pm eastern standard time seattlebusiness wirenanostring technologies inc nasdaq nstg a provider of life science tools for translational research and molecular diagnostic products today announced the appointment of david w ghesquiere as senior vice president corporate  business development effective immediately in this role mr ghesquiere will work with nanostring’s chief executive officer brad gray to shape the strategy of the company while leading nanostring’s corporate and business development efforts his responsibilities will include pursuing growthoriented collaborations transactions and strategic initiatives to leverage and build the company’s technology base diagnostic test pipeline and other value drivers mr ghesquiere joins nanostring with over  years of experience in the biopharmaceutical industry in both north america and europe mr ghesquiere was most recently senior vice president corporate  business development at dendreon corporation where his primary responsibility was leading the strategic process to identify and pursue next generation technologies and therapeutics previously he was an executive at osi pharmaceuticals acquired by astellas where from  to  he held positions of increasing responsibility including senior vicepresident of corporate  business development and served as a board member and managing director  secretary of osi investment holdings gmbh  osi investment management gmbh earlier in his career mr ghesquiere was director of global business development for aventis pharmaceuticals acquired by sanofi and worked in product marketing at johnson  johnson “david has a deep background in the drug development industry and oncology two areas of importance to our strategy” said brad gray president and ceo of nanostring technologies “the addition of david to our executive team will accelerate our efforts to strengthen our menu of molecular diagnostics and extend our reach and impact in the area of oncology drug development” “i believe that molecular diagnostics and nanostring’s ncounter technology in particular will play an important role in improving the lives of patients with cancer and other diseases as the vision of personalized medicine becomes a reality” said mr ghesquiere “i am delighted to join the company to help map out the future for this disruptive technology platform with the potential to revolutionize the practice of oncology” the ncounter analysis system for research applications and the ncounter dx analysis system for highcomplexity cliacertified laboratories are highly automated and easytouse platforms that utilize nanostring’s novel digital barcoding chemistry to deliver high precision multiplexed assays the ncounter dx analysis system supports the prosigna breast cancer prognostic gene signature assay an in vitro diagnostic assay that uses the gene expression profile of cells found in breast cancer tissue to assess a patient’s risk of distant recurrence of disease the prosigna assay is the first in what the company expects to be a portfolio of genomic assays that will benefit cancer patients and oncologists in making treatment decisions about nanostring technologies inc nanostring technologies provides life science tools for translational research and molecular diagnostic products the companys ncounter® analysis system which has been employed in basic and translational research since it was first introduced in  and cited in more than  peerreviewed publications has also now been applied to diagnostic use as the ncounter dx analysis system the companys technology offers a costeffective way to easily profile the expression of hundreds of genes mirnas or copy number variations simultaneously with high sensitivity and precision the companys technology enables a wide variety of basic research and translational medicine applications including biomarker discovery and validation the ncounterbased prosigna™ breast cancer prognostic gene signature assay is the first in vitro diagnostic assay to be marketed through the companys diagnostics business the ncounter dx analysis system is fda k cleared for use with the prosigna breast cancer prognostic gene signature assay to date it has not been cleared by the fda for other indications or for use with other assays the prosigna assay has been cemarked and is available for use by healthcare professionals in the european union and other countries that recognize the ce mark and in which prosigna is registered for more information please visit wwwnanostringcom forward looking statements this press release contains forwardlooking statements within the meaning of the private securities litigation reform act of  including statements regarding the development of additional diagnostic tests and establishment of collaborations or other transactions related to oncology drug development forwardlooking statements are subject to risks and uncertainties that could cause actual results to differ materially and reported results should not be considered as an indication of future performance these risks and uncertainties include but are not limited to risks associated with keeping pace with rapidly changing technology and customer requirements risks regarding our ability to successfully introduce new products risks regarding acceptance of our products by oncologists and companies involved in drug development risks that new market opportunities may not develop as quickly as expected risks associated with competition in marketing and selling products risks of increased regulatory requirements as well as the other risks set forth in the companys filings with the securities and exchange commission these forwardlooking statements speak only as of the date hereof nanostring technologies disclaims any obligation to update these forwardlooking statements the nanostring technologies logo nanostring nanostring technologies ncounter prosigna and ncounter elements are trademarks or registered trademarks of nanostring technologies inc in various jurisdictions contacts for nanostring technologiesmaurissa messier of bioscribe inc 6maurissabioscribecom release summary nanostring technologies provider of life science tools and molecular diagnostic products announced the appointment of david w ghesquiere as senior vice president corporate  business development contacts for nanostring technologiesmaurissa messier of bioscribe inc 6maurissabioscribecom search advanced news search advanced news search log in sign up nanostring technologies names david w ghesquiere senior vice president corporate  business development  business wire welcome register  signin search  jump to a magazine cloud internet of things big data fintech devops containers sdn ai webrtc java linux machine learning microservices cognitive computing mobile security home subscribe advertise authors topics videos events webcasts businesswiresysconcom cloud iot big data fintech devops containers sdn ai webrtc  java linux ml microservices cognitive computing mobile  security business wire subscribe to business wire email alerts get business wire via homepage mobile rss facebook twitter linkedin news feed item nanostring technologies names david w ghesquiere senior vice president corporate  business development by business wire article rating select ratinggive it give it give it give it give it  november    pm est reads  related print email feedback add this blog this nanostring technologies inc nasdaq nstg a provider of life science tools for translational research and molecular diagnostic products today announced the appointment of david w ghesquiere as senior vice president corporate  business development effective immediately in this role mr ghesquiere will work with nanostring’s chief executive officer brad gray to shape the strategy of the company while leading nanostring’s corporate and business development efforts his responsibilities will include pursuing growthoriented collaborations transactions and strategic initiatives to leverage and build the company’s technology base diagnostic test pipeline and other value drivers mr ghesquiere joins nanostring with over  years of experience in the biopharmaceutical industry in both north america and europe mr ghesquiere was most recently senior vice president corporate  business development at dendreon corporation where his primary responsibility was leading the strategic process to identify and pursue next generation technologies and therapeutics previously he was an executive at osi pharmaceuticals acquired by astellas where from  to  he held positions of increasing responsibility including senior vicepresident of corporate  business development and served as a board member and managing director  secretary of osi investment holdings gmbh  osi investment management gmbh earlier in his career mr ghesquiere was director of global business development for aventis pharmaceuticals acquired by sanofi and worked in product marketing at johnson  johnson “david has a deep background in the drug development industry and oncology two areas of importance to our strategy” said brad gray president and ceo of nanostring technologies “the addition of david to our executive team will accelerate our efforts to strengthen our menu of molecular diagnostics and extend our reach and impact in the area of oncology drug development” “i believe that molecular diagnostics and nanostring’s ncounter technology in particular will play an important role in improving the lives of patients with cancer and other diseases as the vision of personalized medicine becomes a reality” said mr ghesquiere “i am delighted to join the company to help map out the future for this disruptive technology platform with the potential to revolutionize the practice of oncology” the ncounter analysis system for research applications and the ncounter dx analysis system for highcomplexity cliacertified laboratories are highly automated and easytouse platforms that utilize nanostring’s novel digital barcoding chemistry to deliver high precision multiplexed assays the ncounter dx analysis system supports the prosigna breast cancer prognostic gene signature assay an in vitro diagnostic assay that uses the gene expression profile of cells found in breast cancer tissue to assess a patient’s risk of distant recurrence of disease the prosigna assay is the first in what the company expects to be a portfolio of genomic assays that will benefit cancer patients and oncologists in making treatment decisions about nanostring technologies inc nanostring technologies provides life science tools for translational research and molecular diagnostic products the companys ncounter® analysis system which has been employed in basic and translational research since it was first introduced in  and cited in more than  peerreviewed publications has also now been applied to diagnostic use as the ncounter dx analysis system the companys technology offers a costeffective way to easily profile the expression of hundreds of genes mirnas or copy number variations simultaneously with high sensitivity and precision the companys technology enables a wide variety of basic research and translational medicine applications including biomarker discovery and validation the ncounterbased prosigna™ breast cancer prognostic gene signature assay is the first in vitro diagnostic assay to be marketed through the companys diagnostics business the ncounter dx analysis system is fda k cleared for use with the prosigna breast cancer prognostic gene signature assay to date it has not been cleared by the fda for other indications or for use with other assays the prosigna assay has been cemarked and is available for use by healthcare professionals in the european union and other countries that recognize the ce mark and in which prosigna is registered for more information please visit wwwnanostringcom forward looking statements this press release contains forwardlooking statements within the meaning of the private securities litigation reform act of  including statements regarding the development of additional diagnostic tests and establishment of collaborations or other transactions related to oncology drug development forwardlooking statements are subject to risks and uncertainties that could cause actual results to differ materially and reported results should not be considered as an indication of future performance these risks and uncertainties include but are not limited to risks associated with keeping pace with rapidly changing technology and customer requirements risks regarding our ability to successfully introduce new products risks regarding acceptance of our products by oncologists and companies involved in drug development risks that new market opportunities may not develop as quickly as expected risks associated with competition in marketing and selling products risks of increased regulatory requirements as well as the other risks set forth in the companys filings with the securities and exchange commission these forwardlooking statements speak only as of the date hereof nanostring technologies disclaims any obligation to update these forwardlooking statements the nanostring technologies logo nanostring nanostring technologies ncounter prosigna and ncounter elements are trademarks or registered trademarks of nanostring technologies inc in various jurisdictions published november    reads  copyright   syscon media inc — all rights reserved syndicated stories and blog feeds all rights reserved by the author related print email feedback add this blog this more stories by business wire copyright   business wire all rights reserved republication or redistribution of business wire content is expressly prohibited without the prior written consent of business wire business wire shall not be liable for any errors or delays in the content or for any actions taken in reliance thereon top reads  this week this month all time klick health’s incubated startup circulation announces new strategic alliances and series a financing closing colleen goggins joins quintilesims board of directors redfin to host seattle event for women in technology on july  kronos acquires global casino resort industry leader digital instinct and its virtual roster product red hat introduces next generation of openshift online public cloud offering northern virginia data center market increases footprint in prince william county recoin group launches recoin  the first ever cryptocurrency backed by real estate la gsma confirme une participation record à lédition  du salon mobile world congress shanghai doctor on demand offers  video visit campaign for state of texas snap inc announces date of second quarter  results conference call polycom introduces polycom® pano™ – the easiest way to share content at work klick health’s incubated startup circulation announces new strategic alliances and series a financing closing colleen goggins joins quintilesims board of directors redfin to host seattle event for women in technology on july  anticipating and mitigating risk keeping data secure and organizations protected kronos acquires global casino resort industry leader digital instinct and its virtual roster product from pepper mills to autonomous robots manufacturing leaders run plex systems charmin® introduces charmin vango the firstever ondemand bathroom service in new york city ge appliances announces new leadership appointments red hat introduces next generation of openshift online public cloud offering onelogin raises m to power expansion red hat us public sector chief technology strategist to speak at nc datapolooza zynga’s farmville becomes largest and fastest growing social game ever timetrade releases “click to schedule” module for drupal kaavo releases web application for easy access to cloud computing wso carbon wso api manager and wso governance registry increase speed scalability and high availability through hazelcast ibc  exhibitor profiles zmanda and sun partner to provide cloud backup vmware virtualization on the iphone boost mobile ofrece nuevos telefonos celulares sin contrato sobre la red nacional de sprint con el plan mensual sin límite commentsnew release of quest toad for oracle offers enhancements to reduce risk by liz mcmillanyourfanat wrote i am using another tool for oracle developers  dbforge studio for oracle this ide has lots of usefull features among them oracle designer code competion and formatter query builder debugger profiler erxportimport reports and many others the latest version supports oracle c more information hereoct    am edtread more  respond » related stories microsoft to release onpremises cloud computing in  csc becomes azure provider sql data services rebranded to ‘sql azure’ microsoft forms server and cloud computing division latest articles latest blogs latest news innovation continues to be a key factor in the smart connected baby monitors market world veterinary software market  opportunities and forecast   research and markets global software market for autonomous cars  geographical segmentation and forecast by technavio nic partners with the national park service for online senior pass sales robots market in oil and gas drilling operations  global forecast and opportunity assessment by technavio correcting and replacing activision blizzard announces launch of new call of duty® black ops iii double duty calling card to support veteran hiring global geospatial imagery analytic market to grow at a cagr of  by  key players are hexagon ab digital globe urthecast corporation trimble harris corporation  google  research and markets smart building market by building automation software building type  services  global forecast to   research and markets global intelligent building automation technologies market  surging demand for integrated security  safety systems  research and markets global tactical communication market to grow at a cagr of  by  key players are harris corporation general dynamics corporation ultra electronics iridium  raytheon company  research and markets more news top stories cloud computing computers and software the dark side of ssh key compliance  cloudexpo cloud compliance slides if iot is the meteor is ot the dinosaur  thingsexpo cisco ai iot mm how sia could disrupt the entire cloud market  cloudexpo cloud fintech blockchain session serverless machine learning operations  cloudexpo hydrospheredata ai ml serverless thwarting ransomware attacks  cloudexpo cloud cybersecurity artificial intelligence electronics and semiconductors a gdpr compliance journey  devopssummit ml cloud agile devops slides the ‘known unknown of big data in iot  thingsexpo oceaninc dx iot mm bigdata the combinatorial nature of digital building blocks  thingsexpo iot mm digitaltransformation session manage your smart home from the cloud  thingsexpo akveloninc ai iot mm video smartcities with interactorteam  thingsexpo iot iiot ai dx bigdata computers and software how does big data affect intellectual property rights  bigdataexpo bigdata security slides reinventing it operations for big data  bigdataexpo ml cloud bigdata digital transformation and competitive decision making  thingsexpo dx iot mm api dxworldexpo to sponsor cloudexpo  ai dx iot fintech smartcities digitaltransformation is your company ready for the general data protection regulation  cloudexpo cloud security analytics iot computers and software brain change and digital strategies  thingsexpo iot mm digitaltransformation what business leaders need to know about machine learning  thingsexpo ai ml iot mm slides trends in webrtc development  thingsexpo webrtcventures ucaas rtc webrtc video mobidev custom software  cloudexpo iot api ai ml ml dx mobile grapeup to exhibit at cloudexpo ca  devops cloudfoundry serverless devopsjournal computers and software lowcode platforms in the era of automation  devopssummit devops automation the four core capabilities of devops  devopssummit agile devops automation slides culture change or die  devopssummit accenture cd agile devops the benefits of building a truly agile team  devopssummit cd agile devops what is java devops  devopssummit apm monitoring microservices continuous integration computers and software video the devops journey with addteq  devopssummit dx chatops session demystifying kubernetes  devopssummit cloudnative serverless devops video value stream management  devopssummit collabnet cloudnative devops enabling devops  devopssummit gluenetworks nfv sdn sdno panel devops  dx  devopssummit andimann digitaltransformation security computers and software network security today  cloudexpo cloud ai sdn security analytics session a live hack simulation  cloudexpo vinnytroia ai dx security how to turn your microwave into a camera  thingsexpo iot mm security insource or outsource the soc  cloudexpo ai soc security analytics should you fear artificialintelligence  cloudexpo bigdata iot ai ml compliance journal financial services multicloud movement  cloudexpo vmware datacenter compliance digitaltransformation don’t get lost in the cloud  cloudexpo rackware compliance ai dx hybridcloud evaluating hybrid cloud  cloudexpo sdn datacenter compliance session enabling fintech  cloudexpo cloudraxak ai ml blockchain divvycloud to exhibit at cloudexpo ny  divvycloud security compliance microservices computers and software is devops falling into the maturity trap  devopssummit agile devops announcing cloudistics named “bronze sponsor” of cloudexpo silicon valley  cloud agile devops itcloud services providers  cloudexpo solarwinds api cloudnative ai dx analytics what is continuous integration and what it isnt  devopssummit ci cd agile devops lowcodenocode is far more disruptive than you think  cloudexpo ai dx sdx devops agile development computers and software video devops – the journey to value stream  devopssummit collabnet agile devops in  it didn’t matter does it matter now  cloudexpo ai dx devops digitaltransformation video simplify complex issues with plantools  cloudexpo cloud agile fintech deconstruction of digitaltransformation  cloudexpo iot ai ml dx what ‘softwaredefined’ really means  cloudexpo ai sdn sdx devops security journal computers and software slides security of smart things  thingsexpo ford iot iiot mm dx smartcities slides iot and the security implications  thingsexpo ntti iiot ai ml dl mm iot and health check  thingsexpo solardwinds iot mm api ai security slides cloud security by design  cloudexpo cloud devops compliance announcing calligocloud named “bronze sponsor” of cloudexpo silicon valley  cloud security agile digital transformation computers and software six ways cios can drive digitaltransformation  devopssummit devops analytics debunking the oslc linkonly myth  devopssummit api agile devops disruptive innovations fuel digitaltransformation  cloudexpo ai dx iot how to sponsor devopssummit  ai dx devops serverless monitoring silicon valley cfp  cloudexpo devops serverless fintech iot ai dx apm computers and software video digital monitoring with catchpoint  devopssummit cloudnative devops video devops and digitaltransformation  devopssummit andimann serverless dx incident management for iot  thingsexpo pagerduty ai iot mm api cloud computing tips to put time and money on your side  cloudexpo cloud apm monitoring promise theory and devops  devopssummit apm ai dx serverless monitoring virtualization computers and software top docker metrics  devopssummit devops apm ai cd monitoring video cloudscale with junipernetworks  cloudexpo cloudnative devops ai dx cloudistics “bronze sponsor” of cloudexpo ny  cloudistics ai devops what is containerization and will it spell the end for virtualization  devopssummit devops containers video ddnlimitless high performance storage  cloudexpo sdn storage datacenter storage computers and software slides alexa manage my storage  devopssummit tintri ai ml devops datacenter what type of file system  cloudexpo compuverdesds sds sdn datacenter session satellite storage for fintech security  cloudexpo ai ml dx video moosefs distributed file systems  cloudexpo cloud ai dx bigdata storage video scaleout storage with storagecraft  cloudexpo sdn datacenter datacenter automation computers and software private cloud the migration path  cloudexpo cloudnative devops dx datacenter video divvycloud automated solutions  cloudexpo ai dx cloudnative devops serverless computing ready for prime time  cloudexpo ai dx serverless digitaltransformation video storage innovation with hdscorp  cloudexpo ai dx sdn datacenter announcing massivenetwork to exhibit at cloudexpo silicon valley  cloud datacenter ecommerce journal retail what digital transformation means to retailers  thingsexpo dx iot mm technology for a cashless society  thingsexpo iot mm sensors improve your ux and you’re bound to see ecommerce success  devopssummit devop webperfs blockchain and smart contracts  cloudexpo fintech bitcoin blockchain what is digitaltransformation  thingsexpo ai dx iot smartcities cloud expo computers and software datera to exhibit at cloudexpo  daterainc cloudnative devops iot ai dx serverless video dhinchcliffes iot keynote  thingsexpo bi ai cio fintech calligo named bronze sponsor of cloudexpo  calligocloud cloudnative devops dx video bigdatadriven devops at devopssummit  iot sdn hadoop ibm named diamond sponsor of cloudexpo ny and ca  ai devops emc journal computers and software can design thinking unleash organizational innovation  thingsexpo iot mm bigdata key to data monetization  cloudexpo iot bigdata analytics ai dx digitaltransformation is blockchain enabler of data monetization  cloudexpo bigdata fintech peter principle and bigdatas  thingsexpo ai ml dx iot iiot mm demystifying datascience  cloudexpo bigdata ai artificialintelligence saas computers and software slides million dollar saas with kubernetes  cloudexpo supergiantio saas cloud devops subscription services  cloudexpo daas xaas cloudnative ai ml dx slides is saas dead  cloudexpo stackarmor saas cloud devops dx arm server to transform bigdata to iot  cloudexpo iiot ai ml dx video interoutes cloud  cloudexpo devops saas ai dx digitaltransformation cio computers and software digital transformation it’s the customer stupid  cloudexpo dx cloud agile preparing for the next disruption  cloudexpo ai dx fintech blockchain devops loses its religion  cloudexpo ai ml iot fintech blockchain beware your digital blind spot  cloudexpo cloud agile digitaltransformation bad pr might sink artificialintelligence  cloudexpo bigdata ai ml dl meap computers and software session reinventing the edge tier  cloudexpo cloudnative devops dx how is apple using machine learning  thingsexpo ai ml dl dx iot mobidev to exhibit cloudexpo ca  mobidev mobile iot ai ml dx beware the wild chatbot  thingsexpo ai iot mm chatbot announcing iotnow “media sponsor” of thingsexpo  iot mm ai business process improvement manufacturing and production does your company require a bb integration tool  cloudexpo bi api cloud business continuity and the cloud  cloudexpo cloud microservices cloud what a business leader must know using business process management and workflow automation the agile pmo cloud data analytics computers and software video cloudistics public cloud  cloudexpo cloudnative ai datacenter slides iot network data analytics  thingsexpo bigdata iot ai dx announcing datanami named “media sponsor” of cloudexpo  bigdata analytics ai dx iot slides kineticadb informercial fintech analytitcs  cloudexpo ai bi dx insurtech session the role of machinelearning  cloudexpo ml iot dx bigdata govit government american airlines adopts public cloud computing  cloudexpo ai cloud analytics managing your hybrid cloud  cloudexpo ai ml cloud cognitive computing crisis response using cloud computing  cloudexpo ml iot ai dx devops fedramp iot new paradigm for connected government  thingsexpo ai dx iot blockchain business innovation  cloudexpo cloud fintech blockchain business intelligence computers and software slides enabling fintechs for success  cloudexpo cloudraxak cloud fintech security make sense of your data with analytics  bigdataexpo bi bigdata analytics it teams and business outcomes  devopssummit plutora ai devops striim to exhibit at cloudexpo ny  striimteam analytics iot ai dx session vodafoneiot to present at thingsexpo ny  ai dx iot mm sap business one computers and software video full potential of cloud  cloudexpo oceaninc sap ai datacenter video oceanincs public cloud  cloudexpo sap cloudnative ai dx session sap in the public cloud  cloudexpo oceaninc cloud analytics security session sap in the cloud  cloudexpo devops iot fintech ai sdn sap releases new sap business bydesign solution govcloud government nato act art of the possible interoperability demonstration both sides of enterprise mobility  cloudexpo cloud mobile digitaltransformation cloudy thinking and digital transformation  cloudexpo dx cloud analytics the byod problem  cloudexpo cloud mobile security how quantum computing with dna storage will affect your health  cloudexpo cloud storage webrtc journal computers and software slides wearables and webrtc  cloudexpo plantronics iot rtc ml slides webrtc for the iot  cloudexpo monteslu mm ai telecom session trends in webrtc development  thingsexpo iot rtc ucaas announcing telecomreseller named “media sponsor” of cloudexpo  cloud rtc ucaas webrtc slides webrtc reborn  cloudexpo danjenkins iot rtc usaas enterprise architect computers and software announcing enterprisetek named “media sponsor” of cloudexpo  iot mm cloudnative white paper transforming enterprise architecture for digital empowerment atomistic and holistic view of an enterprise  cloudexpo ai dx devops datacenter is your enterprise data secure  cloudexpo cloud bigdata analytics how a fresh approach to enterprise architecture drives transformation at dupont pioneer rd syscon media about us contact us company news careers author guidelines syscon events cloud expo big data expo navigate home subscribe advertise downloads whitepapers videos events webcasts international sites india uk canada germany france australia italy spain netherlands brazil belgium magazines net apache ajax cloud computing cms coldfusion crm eclipse open source flex hp   iphone video java linux open web oracle perl php powerbuilder python red hat   ruby search silverlight sap soa symbian virtualization web  weblogic websphere wireless xml terms of use  our privacy statement  about newsfeeds  videofeeds copyright 6 syscon mediaall rights reserved all marks are trademarks of syscon media reproduction in whole or in part in any form or medium without express written permission of syscon media is prohibited login  evaluate retrieving data you are a  user the feature you are trying to access  subscribers please register to access this feature or log in if you are a subscriber or if you have already registered please click the following link to register and submit an upgrade request so that a member of our sales team can contact you to discuss your requirements register and upgrade please click the request upgrade button to log your details so that a member of our sales team can contact you to discuss your additional requirements your request to access this feature is pending you have already logged a callback request a member of our team will contact you to discuss your access level view my contact details   this feature is not yet available we have already attempted to contact you following your recent request we will try and call you again shortly but in the meantime please check that your contact details are correct and up to date or if you prefer please contact us view my contact details   contact us retrieving ep vantage brings a fresh view on pharma and biotech with incisive daily analysis powered by evaluate ltd you are a subscriber to the full evaluate ltd service click here to login to the subscribers welcome page        no i do not want to log in now dont remind me again you are currently accessing our secondary server although the site contains up to date data some features are unfortunately not available on the secondary server we apologise for any inconvenience this may cause close ecommerce support if you would prefer to speak to a member of our sales team please call us on     alternatively if you are experiencing problems with an existing order a member of our support team will be happy to assist you call     telephone lines are open mon  fri am  pm london time alternatively send an email to chrissiepennockevaluategroupcom close shopping cart fetching cart contents please wait please register your details with us to complete your purchase or click login if you have already registered with us     close report summary retrieving report details share with a colleague     show report description this report has already been purchased and is available to view now or you may purchase the report again for the latest data you have already purchased this report but a problem is preventing you from accessing the information it contains before calling a member of our support team please attempt to regenerate your report again from your purchase history page add this item to my basket or regenerate for free this item has already been added to your cart regenerating content    please complete the fields below recipients email    required your email    required your name    required optional message sending email   an email has been successfully sent return to report summary failed to send return to report summary failed to retrieve further details for this product the item has successfully been added to your cart your selected reports will remain in your cart for  days you have succeeded in buying the reports however you havent generated your reports yet please go to purchase history to generate your ordered reports now site maintenance planned the website will be unavailable on thursday  april from pm for routine maintenance please save your work and log out before then remind me later x got it